C2-Symmetric Iridium Emitter for Narrow-Band OLED Emission
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting devices face challenges in achieving high luminescence efficiency and color purity due to limitations in the vibronic state of organometallic compounds used in their emission layers, leading to reduced external quantum efficiency and increased roll-off ratios.
Innovation Solution
The development of a novel organometallic compound with a C2 symmetric structure, represented by Formula 1, which has a specific ligand arrangement and bond distance differences that reduce the vibronic state's symmetry, thereby minimizing the full width at half maximum of photoluminescence and electroluminescence spectra, enhancing color purity and luminescence efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional organometallic compounds are used in the emission layer, then the device structure is simple and easy to manufacture, but the luminescence efficiency is low and color purity is poor due to vibronic state limitations
Solution Approach 1:
The patent applies asymmetry by designing organometallic compounds with C2 symmetric structure where the two L1 ligands are identical but create an asymmetric electronic environment through specific bonding arrangements. The sum of Δ(Ir—N) and Δ(Ir—C) being 0.002 angstroms or less creates a controlled asymmetry that reduces vibronic coupling while maintaining structural stability, thereby improving luminescence efficiency and color purity without complicating the manufacturing process
2Stability of the object's composition
If conventional organometallic compounds with higher symmetry are used, then the structural stability is improved, but the full width at half maximum of photoluminescence spectra increases, reducing color purity
Solution Approach 1:
The C2 symmetric structure with identical L1 ligands provides structural stability through symmetry, while the specific bonding constraints (sum of Δ(Ir—N) and Δ(Ir—C) ≤ 0.002 Å) introduce controlled asymmetry in the electronic structure. This dual approach maintains structural integrity while reducing vibronic coupling, resulting in narrower photoluminescence spectra and improved color purity
3Productivity
If organometallic compounds with reduced vibronic state symmetry are used, then color purity and luminescence efficiency are enhanced, but the device complexity increases due to specific ligand arrangement requirements
Solution Approach 1:
The patent uses C2 symmetric structure with identical L1 ligands to achieve reduced vibronic coupling, improving luminescence efficiency and color purity. The specific bonding constraints (sum of Δ(Ir—N) and Δ(Ir—C) ≤ 0.002 Å) provide a clear design guideline that simplifies the optimization process despite the apparent complexity of the ligand arrangement requirements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of this organometallic compound in organic light-emitting devices results in improved maximum external quantum efficiency and reduced roll-off ratios, leading to higher emission efficiency and longer lifespan with lower driving voltage.
Implementation Method 1
minimizing the full width at half maximum of photoluminescence and electroluminescence spectra
Implementation Method 2
minimizing the full width at half maximum of photoluminescence and electroluminescence spectra
Data Source
AI summary
An organometallic compound, wherein the organometallic compound has a C2 symmetric structure, and is represented by Formula 1,wherein the sum of Δ(Ir—N) and Δ(Ir—C) is about 0.002 angstroms or less:Ir(L1)2(L2) Formula 1wherein, in Formula 1,L1 is a ligand represented by Formula 2 as provided herein, wherein one of two L1s is a first L1 ligand and the other L1s is a second L1 ligand and the first L1 ligand and the second L1 ligand are identical to each other,L2 is a ligand represented by Formula 3 as provided herein, andΔ(Ir—N) and Δ(Ir—C) are as defined herein.